VANDA PHARMACEUTICALS INC. (VNDA) Operating margin 2016–2025
VANDA PHARMACEUTICALS INC. (VNDA) operating margin by fiscal year — reported operating income divided by reported revenue.
-70.0%FY2025 · since FY2016: -12.7% → -70.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -70.0% | -49.5 pp |
| FY2024 | -20.5% | -13.2 pp |
| FY2023 | -7.2% | -9.7 pp |
| FY2022 | 2.5% | -13.2 pp |
| FY2021 | 15.7% | +4.7 pp |
| FY2020 | 11.0% | +0.9 pp |
| FY2019 | 10.0% | -1.2 pp |
| FY2018 | 11.3% | +21.5 pp |
| FY2017 | -10.2% | +2.5 pp |
| FY2016 | -12.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice